GTBP
GTBP
NASDAQ · Biotechnology

Gt Biopharma Inc

$0.54
+0.04 (+8.54%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.23M 4.16M 3.54M
Net Income -163,651 -194,157 -147,578
EPS
Profit Margin -3.9% -4.7% -4.2%
Rev Growth +8.4% +2.1% +5.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.36M 2.22M 1.86M
Total Equity 10.06M 10.08M 9.46M
D/E Ratio 0.23 0.22 0.20
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -229,901 -240,916 -206,498
Free Cash Flow -133,630 -165,029 -157,801